Intelligence Β· Clinical Pipeline
First People's Hospital Pipeline
All ClinicalTrials.gov programs at First People's Hospital β phase, modality, and trial IDs.
- Programs
- 1,136
Quick answer
First People's Hospital has 1,136 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Cohort A will receive an initial load dose of 8mg/kg and a maintenance dose of 6mg/kg intravenously on the first day of every three weeks for a total of 4 doses
The First People's Hospital of Lianyungang
HER2 Positive Breast Cancer
1 trial -
Combination of antiplatelet drugs and anticoagulants for at least one month
The First People's Hospital of Lianyungang
Acute Myocardial Infarction
1 trial -
Dabigatran Etexilate
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial -
Dapagliflozin 10 MG
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus
1 trial -
Daphnetin
The First People's Hospital of Lianyungang
Lower Extremity Lymphedema
1 trial -
Dental foam "Biorepair PERIBIOMA"
The First People's Hospital of Lianyungang
Oral Health
1 trial -
Desmopressin
The First People's Hospital of Lianyungang
Patients Undergoing Endoscopic Sinus Surgery
1 trial -
Dex-Esk
The First People's Hospital of Lianyungang
Older Patients
1 trial -
Dexamethasone
The First People's Hospital of Lianyungang
Carcinoma, Non-Small-Cell Lung
1 trial -
Dexamethasone
The First People's Hospital of Lianyungang
Pancreatic Cancer
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Overall Survival
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Postoperative Delirium After Living Donor Renal Transplantation
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Renal Function
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Obstructive Sleep Apnea
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Elderly
3 trials -
Dexmedetomidine
The First People's Hospital of Lianyungang
Older Patients
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Dexmedetomidine-esketamine combination
The First People's Hospital of Lianyungang
Obstructive Sleep Apnea
1 trial -
Diane-35 pretreatment
The First People's Hospital of Lianyungang
Polycystic Ovary Syndrome
1 trial -
Edaravone dexborneol
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Postpartum Depression
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Scoliosis Correction
1 trial -
Esketamine 0.2 mg/kg
The First People's Hospital of Lianyungang
Cesarean Delivery
1 trial -
Esketamine 1
The First People's Hospital of Lianyungang
Elderly
1 trial -
Esketamine combined with dexmedetomidine
The First People's Hospital of Lianyungang
Dexmedetomidine
2 trials -
Exenatide
The First People's Hospital of Lianyungang
Type 2 Diabetes
1 trial -
Flumatinib
The First People's Hospital of Lianyungang
Flumatinib
1 trial -
Folic Acid
The First People's Hospital of Lianyungang
Hypertension
1 trial -
Fosinopril
The First People's Hospital of Lianyungang
Chronic Kidney Disease
1 trial -
Glucagon-like peptide-1 receptor agonistοΌSemaglutide
The First People's Hospital of Lianyungang
Type 2 Diabetes
1 trial -
Glycopyrronium in Combination With Tropisetron
The First People's Hospital of Lianyungang
Postoperative Nausea and Vomiting
1 trial -
Henagliflozin Proline Tablets treatment
The First People's Hospital of Lianyungang
Diabetes Type 2
1 trial -
High-dose anrikefon
The First People's Hospital of Lianyungang
Laparoscopic Surgery
2 trials -
Honghe Fujie lotion
The First People's Hospital of Lianyungang
Bacterial Vaginitis
1 trial -
Hydroxychloroquine Sulfate
The First People's Hospital of Lianyungang
Primary IgA Nephropathy
1 trial -
Hydroxychloroquine Sulfate 200 Mg Tablet
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial -
ICS/LABA
The First People's Hospital of Lianyungang
Asthma
1 trial -
IVC
The First People's Hospital of Lianyungang
Proliferative Diabetic Retinopathy
1 trial -
Icodextrin Peritoneal Dialysis Solution
The First People's Hospital of Lianyungang
Peritoneal Dialysis
1 trial -
Individual ATG
The First People's Hospital of Lianyungang
Hematopoietic Stem Cell Transplantation
1 trial -
Infliximab
The First People's Hospital of Lianyungang
Crohn's Diseases
1 trial -
Insulin
The First People's Hospital of Lianyungang
Brain Injuries
1 trial -
Insulin
The First People's Hospital of Lianyungang
Acute Pancreatitis
1 trial -
Intranasal dexmedetomidine-esketamine
The First People's Hospital of Lianyungang
Adenotonsillectomy
1 trial -
Intravenous Immunoglobulins, Human
The First People's Hospital of Lianyungang
Guillain-Barre Syndrome
1 trial -
Intravenous thrombolysis + edaravone
The First People's Hospital of Lianyungang
Ischemic Stroke
1 trial -
Irinotecan liposomes combined with cisplatin/carboplatin
The First People's Hospital of Lianyungang
Neuroendocrine Tumors
1 trial -
Ixazomib
The First People's Hospital of Lianyungang
Multiple Myeloma
1 trial
Frequently asked questions
How many pipeline programs does First People's Hospital have?
1,136 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources Β· All pipeline programs